Back to Directory
Avenna
South East England
Founded 2017
Blood glycomic biomarkers for chronic inflammatory disease detection and monitoring
Avenna is a biotechnology company developing blood-based glycomic biomarkers for chronic inflammatory diseases.
Its tests analyse the sugar structures attached to blood proteins to measure chronic inflammation separately from short-term acute inflammation, supporting early detection, disease monitoring and personalised treatment in conditions such as inflammatory bowel disease and rheumatoid arthritis.
The company serves clinicians, individuals and pharmaceutical developers, including companion diagnostic support for patient selection in clinical trials.